N-able, Inc.
NABL NYSE Services-Prepackaged Software Financials FY2019βFY2025
Last close Β· Oct 23, 2026
$5.12
4.1%What N-able, Inc. does
No business description yet.
- Legal name
- N-able, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001834488-26-000007
0001834488
Revenue and margins
N-able, Inc. had $509M of revenue in fiscal 2025, up 9.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $75.1M in fiscal 2025, 14.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
N-able, Inc. returned β to shareholders in fiscal 2025. The diluted share count fell 0.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably N-able, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $66.7M | $98.8M | $153M | $85.2M | $112M |
| Debt incl. finance leases | $339M | $337M | $335M | $333M | $394M |
| Net debt / EBITDA | 4.1x | 3.3x | 2.0x | 2.3x | 3.6x |
| Debt / equity | 0.5x | 0.5x | 0.5x | 0.4x | 0.5x |
| Current ratio | 2.0x | 2.5x | 2.8x | 1.2x | 1.2x |
| Quick ratio | 2.0x | 2.5x | 2.8x | 1.2x | 1.2x |
| Total assets | $1.1B | $1.1B | $1.2B | $1.3B | $1.4B |
| Total liabilities | $437M | $437M | $451M | $580M | $608M |
| Shareholders' equity | $618M | $642M | $712M | $760M | $802M |
| Net debt (β = net cash) | $272M | $238M | $182M | $248M | $282M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 6 / 9 | 7 / 9 | 7 / 9 | 5 / 9 | 4 / 9 |
| Accruals ratio | β | β8.6% | β4.2% | β5.1% | β5.9% | β3.9% | β8.2% |
| Altman Z'' | β | 2.18 | 2.07 | 2.45 | 2.98 | 2.13 | 1.82 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $264M | $303M | $346M | $372M | $422M | $466M | $509M |
| Gross profit | $206M | $240M | $294M | $313M | $354M | $385M | $391M |
| Research and development | $37.2M | $42.7M | $54.0M | $63.5M | $78.2M | $90.7M | $101M |
| Operating income | $36.6M | $33.8M | $33.3M | $47.4M | $70.4M | $81.9M | $33.9M |
| Pretax income | $3.2M | $4.9M | $11.6M | $30.4M | $44.7M | $54.1M | β$0.2M |
| Income tax | $5.7M | $12.0M | $11.5M | $13.7M | $20.9M | $23.3M | $18.6M |
| Net income | β$2.5M | β$7.2M | $0.1M | $16.7M | $23.8M | $30.7M | β$18.8M |
| Net income to common | β$2.5M | β$7.2M | $0.1M | $16.7M | β | β | β |
| Diluted EPS | β$0.02 | β$0.05 | $0.00 | $0.09 | $0.13 | $0.16 | β$0.10 |
| Diluted shares | 0.16B | 0.16B | 0.17B | 0.18B | 0.19B | 0.19B | 0.19B |
| Cash flow | |||||||
| Cash from operations | $25.5M | $85.7M | $45.3M | $71.4M | $90.1M | $79.4M | $93.2M |
| Capital expenditure | $5.8M | $11.9M | $30.7M | $12.8M | $13.8M | $17.6M | $18.1M |
| Free cash flow | $19.7M | $73.7M | $14.7M | $58.6M | $76.3M | $61.9M | $75.1M |
| Depreciation and amortization | $54.1M | $56.5M | $33.8M | $24.4M | $21.7M | $25.9M | $44.4M |
| Stock-based compensation | $8.7M | $21.1M | $29.4M | $36.5M | $43.6M | $45.4M | $46.6M |
| Acquisitions | $14.8M | $0.0M | $0.0M | $9.2M | $0.0M | $98.7M | $0.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $39.3M | $99.8M | $66.7M | $98.8M | $153M | $85.2M | $112M |
| Total debt | β | $0.0M | $339M | $337M | $335M | $333M | $394M |
| Current assets | β | $136M | $121M | $154M | $225M | $184M | $216M |
| Current liabilities | β | $54.8M | $60.9M | $61.8M | $81.7M | $150M | $184M |
| Property and equipment, net | β | $19.6M | $38.7M | $37.4M | $36.8M | $36.6M | $38.4M |
| Goodwill | $837M | $874M | $841M | $829M | $838M | $977M | $1.0B |
| Intangible assets | β | $27.4M | $8.1M | $8.9M | $6.7M | $83.2M | $64.8M |
| Total assets | β | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | $1.4B |
| Total liabilities | β | $449M | $437M | $437M | $451M | $580M | $608M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $564M | $631M | $618M | $642M | $712M | $760M | $802M |
| Margins | |||||||
| Gross margin | 78.2% | 79.1% | 84.9% | 84.2% | 83.8% | 82.6% | 76.9% |
| Operating margin | 13.9% | 11.1% | 9.6% | 12.7% | 16.7% | 17.6% | 6.7% |
| EBITDA margin | 34.4% | 29.8% | 19.4% | 19.3% | 21.8% | 23.2% | 15.4% |
| Net margin | β1.0% | β2.4% | 0.0% | 4.5% | 5.6% | 6.6% | β3.7% |
| FCF margin | 7.5% | 24.3% | 4.2% | 15.8% | 18.1% | 13.3% | 14.8% |
| Returns | |||||||
| Return on capital | β | 4.1% | 2.4% | 3.5% | 5.1% | 5.3% | 2.5% |
| Return on capital employed | β | 3.3% | 3.4% | 4.7% | 6.5% | 6.9% | 2.8% |
| Return on equity | β0.4% | β1.2% | 0.0% | 2.7% | 3.5% | 4.2% | β2.4% |
| Return on assets | β | β0.7% | 0.0% | 1.6% | 2.1% | 2.5% | β1.4% |
| Growth | |||||||
| Revenue growth | β | 14.9% | 14.4% | 7.3% | 13.6% | 10.3% | 9.3% |
| Net income growth | β | β | β | 14,685.0% | 42.6% | 29.1% | β161.2% |
| EPS growth | β | β | β | β | 44.4% | 23.1% | β162.5% |
| FCF growth | β | 273.5% | β80.1% | 299.1% | 30.3% | β18.9% | 21.3% |
| Share count change | β | 0.0% | 6.7% | 7.5% | 2.6% | 1.3% | β0.3% |
| Financial health | |||||||
| Net debt / EBITDA | β | β1.1x | 4.1x | 3.3x | 2.0x | 2.3x | 3.6x |
| Debt / equity | β | 0.0x | 0.5x | 0.5x | 0.5x | 0.4x | 0.5x |
| Current ratio | β | 2.5x | 2.0x | 2.5x | 2.8x | 1.2x | 1.2x |
| Quick ratio | β | 2.5x | 2.0x | 2.5x | 2.8x | 1.2x | 1.2x |
| Capital allocation | |||||||
| Capex / revenue | 2.2% | 3.9% | 8.9% | 3.5% | 3.3% | 3.8% | 3.6% |
| Stock comp / revenue | 3.3% | 7.0% | 8.5% | 9.8% | 10.3% | 9.7% | 9.2% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 6.0 | 7.0 | 7.0 | 5.0 | 4.0 |
| Altman Z'' | β | 2.2 | 2.1 | 2.5 | 3.0 | 2.1 | 1.8 |
| Accruals ratio | β | β8.6% | β4.2% | β5.1% | β5.9% | β3.9% | β8.2% |
Source: SEC EDGAR XBRL filings (CIK 0001834488). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.